Latest autoimmune diseases Stories
More than $300,000 raised to support research, education and support services for people affected by lupus LOS ANGELES, Sept.
Companies Include Silarus Therapeutics Developing Treatments for Anemia and Iron Overload Disorders; and Thyritope Biosciences Developing Treatments for Graves' Orbitopathy SAN DIEGO,
TOORAK, Australia, Sept.
Arthritis Society says patient safety paramount as new class of medications become available Toronto, ON (PRWEB) September 18, 2014 With the arrival
Company Recently Initiated Phase II in Bullous Pemphigoid CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, Sept. 18, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc.
Improved Efficacy and Lower List Price than the Anti-TNFs Will Be the Key Drivers for Prescribing of Emerging Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass.,
Hundreds Step Up For New Lupus Treatments NEW YORK, Sept.
- Research grants awarded for five out of more than 200 proposals, highlighting continued commitment to multiple sclerosis (MS) ROCKLAND, Mass., Sept.
- Currently no approved treatment options available for patients living with HS, a skin disease which impacts approximately 1 percent of the adult population worldwide1,2 COPENHAGEN, Denmark,
Lupus Foundation of America and Rheumatology Research Foundation hold congressional briefing WASHINGTON, Sept.
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.